Evidence map›Paper›PMID 40524944›Full record

ArticleJournal of immunology research2025

The Molecular Mechanisms of Imatinib Treatment on Acute Lung Injury in Septic Mice Through Proteomic Technology.

Xiao Wang, ZhiQing Zhou, DuanYang Li, BoYang Zhang, XiaoLong Zong, Xue Liang, ZhenYu Li

Abstract read
In one paragraph

Article in Journal of immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. CEBPD-MMP8 Axis Contributes to Cardiomyocyte Injury in Septic Shock.Applied biochemistry and biotechnology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiao WangDepartment of Emergency Medicine, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.
ZhiQing ZhouDepartment of Emergency Medicine, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.
DuanYang LiDepartment of Emergency Medicine, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.
BoYang ZhangDepartment of Emergency Medicine, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.
XiaoLong ZongDepartment of Clinical Laboratory, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.
Xue LiangTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.ORCID https://orcid.org/0000-0001-7134-0182
ZhenYu LiDepartment of Emergency Medicine, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.ORCID https://orcid.org/0000-0003-4431-1049

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Lung InjuryImatinib MesylateSepsisAnimalsComputational BiologyDisease Models, AnimalLipopolysaccharidesLungMaleMiceProteomeProteomicsSignal TransductionImatinib MesylateLipopolysaccharidesProteomeacute lung injuryimatinibproteomicssepsis

Identifiers

PMID40524944
PMCPMC12170088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.